2,218
Views
41
CrossRef citations to date
0
Altmetric
Commentary

Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design

, , ORCID Icon &
Pages 1288-1296 | Received 19 Jan 2017, Accepted 30 Jan 2017, Published online: 03 Apr 2017

Figures & data

Figure 1. Possible mechanisms of influenza-specific ADCC. (A) Differential ability of HA-specific mAbs to mediate ADCC. Mabs targeting regions of influenza virus HA (stem or head region) have the ability to mediate ADCC (HAI head-specific mAbs or stem-specific mAbs), cannot mediate ADCC (HAI+ head-specific mAbs) or inhibit ADCC (HAI + head-specific with stem-specific mAbs). (B) Potential role of neutralizing and non-neutralizing (including ADCC-Abs) antibodies against seasonal influenza viruses that antigenically drift through influenza seasons. High concentractions of neutralizing antibodies against seasonal influenza virus entry before infection is established, such as following "matched" seasonal influenza vaccination or homologous influenza control of virus infection. Moderate neutralization and cross-reactive non-nuetralizing antibodies may lead to some infection but provide rapid control of virus infection and clearance, as maybe the case following vaccine miss-match or heterologous influenza infection. Low neutralizing and high cross-reactive non-neutralizing antibodies may not prevent influenza virus infection but reduce the severity of influenza infection.

Figure 1. Possible mechanisms of influenza-specific ADCC. (A) Differential ability of HA-specific mAbs to mediate ADCC. Mabs targeting regions of influenza virus HA (stem or head region) have the ability to mediate ADCC (HAI− head-specific mAbs or stem-specific mAbs), cannot mediate ADCC (HAI+ head-specific mAbs) or inhibit ADCC (HAI + head-specific with stem-specific mAbs). (B) Potential role of neutralizing and non-neutralizing (including ADCC-Abs) antibodies against seasonal influenza viruses that antigenically drift through influenza seasons. High concentractions of neutralizing antibodies against seasonal influenza virus entry before infection is established, such as following "matched" seasonal influenza vaccination or homologous influenza control of virus infection. Moderate neutralization and cross-reactive non-nuetralizing antibodies may lead to some infection but provide rapid control of virus infection and clearance, as maybe the case following vaccine miss-match or heterologous influenza infection. Low neutralizing and high cross-reactive non-neutralizing antibodies may not prevent influenza virus infection but reduce the severity of influenza infection.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.